The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, Y.
Right arrow Articles by Shibuya, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, Y.
Right arrow Articles by Shibuya, N.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Myasthenia Gravis
The Journal of Immunology, 2006, 176: 5100-5107.
Copyright © 2006 by The American Association of Immunologists

CDR3 Spectratyping Analysis of the TCR Repertoire in Myasthenia Gravis1

Yoh Matsumoto2,*, Hidenori Matsuo{dagger},{ddagger}, Hiroshi Sakuma*, Il-Kwon Park*, Yukiko Tsukada*, Kuniko Kohyama*, Takayuki Kondo{dagger}, Satoshi Kotorii{dagger} and Noritoshi Shibuya{dagger},{ddagger}

* Department of Molecular Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, Japan; {dagger} Division of Clinical Research and Department of Neurology, National Hospital Organization, Nagasaki Medical Center of Neurology, and {ddagger} Department of Clinical Neurosciences, Nagasaki University Graduate School of Biomedical Sciences, Kawatana, Nagasaki, Japan

Because myasthenia gravis (MG) is an autoimmune disease mediated by Abs specific for the acetylcholine receptor, helper T cells play a role in Ab production. In this study, we have performed large-scale cross-sectional and longitudinal TCR studies by CDR3 spectratyping using PBL and thymus tissues from MG patients. We found that there was no preferential usage of any particular TCR beta-chains that was identical among MG patients. However, the longitudinal study clearly demonstrated that one or more TCR Vbeta expansions persisted frequently in MG patients. Importantly, persistent TCR expansions correlated with clinical severity and high anti-acetylcholine receptor Ab titer. Finally, examinations of T cells expressing CXCR5, i.e., follicular B-helper T cells, revealed that spectratype expansions in MG patients were detected mainly in the CD4+ CXCR5+ T cell populations, whereas CD8+ T cells were the major source of clonal expansion in healthy subjects. These findings suggest that persistent clonal expansions of T cells in MG patients are associated with the development and maintenance of MG. Close examination of pathogenic T cells in MG provides useful information to elucidate the pathogenesis and to estimate the disease status.




This article has been cited by other articles:


Home page
Int ImmunolHome page
L. Zheng, R. Sharma, J. T. Kung, U. S. Deshmukh, W. N. Jarjour, S. M. Fu, and S.-T. Ju
Pervasive and stochastic changes in the TCR repertoire of regulatory T-cell-deficient mice
Int. Immunol., April 1, 2008; 20(4): 517 - 523.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.